510(k) Report

510(k) · Cleared

Cleared

FilmArray Pneumonia/Pneumoniaplus Control

K190222510(k) TraditionalCleared May 3, 201987-day reviewClass II21 CFR 866.3920

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Maine Molecular Quality Controls, Inc. · PMN Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays

Cleared on May 3, 2019 as substantially equivalent to K161573 (Maine Molecular Quality Controls, Inc., 2016) after an 87-day review. Its family tree reaches back 2 generations to 2016. 8 later devices descend from it.

Decided
May 3, 2019
Review
87 days
Class
Class II
Product code
PMN
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN150058 (2016). 8 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2020: 1 descendant cleared2022: 2 descendants cleared2023: 2 descendants cleared2026: 3 descendants clearedDEN150058 · Amplichek II, Negative and Amplichek II, Negative MiniPak, Amplichek II, Level 1 and Amplichek II, Level 1 MiniPak, Amplichek II, Level 2 and Amplichek II, Level 2 MiniPak, Amplichek II, Level 3 and Amplichek II, Level 3 MiniPak · Bio-Rad Laboratories · 2016K161573 · FilmArray RP EZ Control Panel M265 · Maine Molecular Quality Controls, Inc. · 2016201620182020202220242026
  1. Root · 2 generations backDEN150058 Amplichek II, Negative and Amplichek II, Negative MiniPak, Amplichek…Bio-Rad Laboratories · 2016
  2. 1 generation backK161573 FilmArray RP EZ Control Panel M265Maine Molecular Quality Controls, Inc. · 2016
  3. This deviceK190222 FilmArray Pneumonia/Pneumoniaplus ControlMaine Molecular Quality Controls, Inc. · 2019
  4. Descendant · cites it directly · 7 of its ownK200010 FilmArray BCID2 Control Panel M416Maine Molecular Quality Controls, Inc. · 2020
  5. Descendant · 2 generations on · 5 of its ownK212576 MDx-Chex for BCID2Streck, Inc. · 2022
  6. Descendant · 3 generations on · 1 of its ownK231221 MDx-Chex for BC-GPStreck · 2023
  7. Descendant · 3 generations on · 1 of its ownK231223 MDx-Chex for BC-GNStreck · 2023
  8. Descendant · 4 generations on · 0 of its ownK260041 MDx-Chex for BCPStreck, LLC · 2026

Showing 5 of 8 descendants. See all descendants

Descendants cleared per year

2020: 12022: 22023: 22026: 3
2020high 3 (2026) · low 0 (2021)2026

Most influential descendants

Showing 5 of 8 · See all
  • K200010FilmArray BCID2 Control Panel M416Maine Molecular Quality Controls, Inc. · 2020 · cites it directly7descendants
  • K212576MDx-Chex for BCID2Streck, Inc. · 2022 · 2 generations on5descendants
  • K231221MDx-Chex for BC-GPStreck · 2023 · 3 generations on1descendant
  • K231223MDx-Chex for BC-GNStreck · 2023 · 3 generations on1descendant
  • K260041MDx-Chex for BCPStreck, LLC · 2026 · 4 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN150058Amplichek II, Negative and Amplichek II, Negative MiniPak, Amplichek II, Level…Bio-Rad Laboratories2016—
−1K161573FilmArray RP EZ Control Panel M265Maine Molecular Quality Controls, Inc.2016—
0 (this device)K190222FilmArray Pneumonia/Pneumoniaplus ControlMaine Molecular Quality Controls, Inc.2019—
+1K200010FilmArray BCID2 Control Panel M416Maine Molecular Quality Controls, Inc.2020—
+2K212576MDx-Chex for BCID2Streck, Inc.2022—
+3K231221MDx-Chex for BC-GPStreck2023—
+3K231223MDx-Chex for BC-GNStreck2023—
+4K260041MDx-Chex for BCPStreck, LLC2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
202220
202320
202630
FIG. 1 — Lineage of K190222, 2016–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PMN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PMN device

  1. #1 K251526 FilmArray GI Control Panel M238score 13.7 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K161573FilmArray RP EZ Control Panel M265
Summary page 4
…21 CFR 866.3920 Panel: Microbiology - 83 Product code: PMN Predicate Device K161573; FilmArray RP EZ Control Panel M265, Maine Molecular Quality Controls, Inc. Device Description FilmArray Pneumonia/Pneumoniaplus…
Maine Molecular Quality Controls, Inc.2016—

Also cleared against K161573: 2 other devices →

What descends from it? (8)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K200010FilmArray BCID2 Control Panel M416Maine Molecular Quality Controls, Inc.20207

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 2 companies; a new generation was cleared every 2.7 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K200010 (Maine Molecular Quality Controls, Inc., 2020) has gone furthest, with 7 descendants of its own.
  • 2 other devices also cite its predicate K161573.

How does its category compare?

All PMN devices

PMN Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · PMN

1in 2025

2016: 32017: 22018: 32019: 62020: 22021: 12022: 32023: 42024: 22025: 12026 (partial year): 6
2007high 6 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PMN

90in 2023

2018: 59 days median2019: 71 days median2022: 582 days median2023: 90 days median2026 (partial year): 85 days median
2007high 582 (2022) · low 59 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PMN

1in 2019

2019: 1
2007high 1 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PMN

1in 2023

2023: 1
2007high 1 (2023) · low 0 (2007)2025

MAUDE reports naming product code PMN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20163—00
20172—00
201835900
201967110
20202—00
20211—00
2022358200
202349001
20242—00
20251—00
20266850—

What is it indicated for?

FilmArray Pneumonia/Pneumoniaplus Control is intended for use as an external positive and negative assayed quality control to monitor performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of bacteria: Acinetobacter calcoaceticus-baumannii complex, Enterobacter cloacae complex, Escherichia coli, Haemophilus influenzae, Klebsiella aerogenes, Klebsiella oxytoca, Klebsiella pneumoniae group, Moraxella catarrhalis…

Read the full statement (167 words)

FilmArray Pneumonia/Pneumoniaplus Control is intended for use as an external positive and negative assayed quality control to monitor performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of bacteria: Acinetobacter calcoaceticus-baumannii complex, Enterobacter cloacae complex, Escherichia coli, Haemophilus influenzae, Klebsiella aerogenes, Klebsiella oxytoca, Klebsiella pneumoniae group, Moraxella catarrhalis, Proteus spp., Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Chlamydia pneumoniae, Legionella pneumophila, Mycoplasma pneumoniae; antimicrobial resistance genes: CTX-M, IMP, KPC, mecA/C and MREJ, NDM, OXA-48 like, VIM; and viruses: Adenovirus, Coronavirus, Human Metapneumovirus, Human Rhinovirus/Enterovirus, Influenza A, Influenza B, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Parainfluenza Virus and Respiratory Syncytial Virus on the FilmArray Pneumonia Panel or Pneumonia Panel plus assays performed on FilmArray systems. FilmArray Pneumonia/Pneumoniaplus Control is composed of synthetic DNA and RNA designed for and intended to be used solely with the FilmArray Pneumonia Panel and FilmArray Pneumonia Panel plus assays. This product is not intended to replace manufacturer internal controls provided with the test system.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K190222: FilmArray Pneumonia/Pneumoniaplus Control.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K190222

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026